Implementing systematic reviews of prognosis studies in Cochrane
Karel GM Moons, Lotty Hooft, Katrina Williams, Jill A Hayden, Johanna AAG Damen, Richard D Riley
Cochrane Database of Systematic Reviews | WILEY | Published : 2018
The authors have completed the ICMJE form for disclosure of potential conflicts of interest (forms available on request). The authors are the coordinator (JAAGD) and convenors (other authors) of the Cochrane Prognosis Methods Group (methods.cochrane.org/prognosis). KGMM is Director of Research of a large (around 500 employees) research and teaching institute within Utrecht University Medical Center. The institute conducts both investigator-and industry-driven research projects with a number of pharmaceutical and diagnostic companies. In addition, some of the members of staff receive unrestricted grants for research projects from a number of companies. It is the institute's explicit policy to work with several companies and not to focus on one or two industrial partners. KGMM receives no personal payment from any industrial partner. JH reports funding from the Cochrane Strategic Methods Fund and the Cochrane Methods Innovation Fund in relation to the work described in this Editorial. RDR also receives funding from HHR and other sources to conduct prognosis research in general but received no funding for this Editorial. The authors have no other disclosures.